	The Real-World Safety Profile of Immune Checkpoint Inhibitors in Melanoma: FAERS Pharmacovigilance Analysis Complemented by Randomized Trial Evidence. Health Sci Rep Chen Y, Liang X, Chen X, Li Y. PMID: 42524550 [PubMed - as supplied by publisher]
	Investigating the causal association between liver condition and melanoma: evidence from the National Health and Nutrition Examination Survey and Mendelian randomization. Melanoma Res Song B, Guo S, Li Q, Li Z, Bi J. PMID: 42522640 [PubMed - as supplied by publisher]
	The cost of AI sycophancy in dermoscopic diagnosis. Comment on "Framing Bias in a large language model: prompt framing influences ChatGPT's accuracy in melanoma classification. A diagnostic accuracy study". J Am Acad Dermatol Nouyed MI, Adjeroh DA, Xu D, Kolodney MS, Hu G. PMID: 42521024 [PubMed - as supplied by publisher]
	Updating melanoma therapy regarding melanin structure: Advances and proposals from biophysics, histochemistry and cell biology. Acta Histochem Stockert JC, Blázquez-Castro A. PMID: 42520533 [PubMed - as supplied by publisher]
	Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) -Â a single arm, phase 2 clinical trial. Front Oncol Icht O, Sun A, Wong P, McPartlin A, Muniz TP, Spreafico A, Saibil SD, Lukens JN, Karam SD, De Almeida J, Butler MO, Tsai CJ. PMID: 42518820 [PubMed - as supplied by publisher]
	Decoding Post-Transcriptional Networks Governing the Melanoma Extracellular Matrix. Cancers (Basel) Katsoulieris EN, Ioannou P, Afratis NA. PMID: 42512389 [PubMed - in process]
	Current Molecular-Targeted Therapies in Melanoma and Their Mechanism of Resistance. Cancers (Basel) Bahari R, Nguyen M, Sohail N, Lopez S, Saravanaguru Vasanthi S, Amin J, Ramaswami D, Kapetaneas G, Karne R, Altayeh U, Rodgers KJ, Mehta AP, Puri N. PMID: 42512373 [PubMed - in process]
	A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma. Cancers (Basel) Seedor RS, Terai M, Koshkin S, Aplin AE, Orloff M, Sharpe-Mills E, Naccarato M, Mills A, Molinolo AA, Gutkind JS, Sato T. PMID: 42512298 [PubMed - in process]
	Imaging in Cutaneous Melanoma: Current Workup, Surveillance, and Emerging Directions. Cancers (Basel) Willem H, Aguilar T, Cowman AW, Lourdault K, Essner R. PMID: 42512282 [PubMed - in process]
	Melanoma Detection in Pigmented Lesions â‰¤ 6 mm Selected for Excision After Dermoscopy in Routine Practice: A Retrospective Cross-Sectional Study. Cancers (Basel) De Giorgi V, Cecchi G, Marabini V, Gurioli G, Perillo G, Fazzari F, Zuccaro B. PMID: 42512250 [PubMed - in process]
	Combination of Three Herbal Components (ISL, Que, Meth) Suppresses Uveal Melanoma Growth via GÎ±q/MEK/YAP Axis Modulation and Apoptosis. Biomedicines Zhang X, Wu R, Yan C, Wang R, Zhang Y. PMID: 42512070 [PubMed - in process]
	Pre-Treatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers for Sentinel Lymph Node Positivity and Recurrence-Free Survival in Primary Cutaneous Melanoma: An Exploratory Single-Centre Retrospective Cohort Study. Biomedicines Grigore R, Fericean RM, Badea MA, Brad S, Ilie AC, Sirbu MIC, Tanase AD, Bratiloveanu CT. PMID: 42512065 [PubMed - in process]
	MicroRNAs and Cellular Senescence in Melanoma: An Underexplored Link to Tumor Progression-A Systematic Review with Bioinformatics Analyses. Int J Mol Sci Beganovi, Marcansoni T, Lazzari V, Vargas JE. PMID: 42511805 [PubMed - in process]
	Photodynamic Therapy for Keratinocytic Precancerous Lesions and Non-Melanoma Skin Cancer: A Narrative Review. Int J Mol Sci Russano F, Dall'Olmo L, Brugnolo D, Callegarin F, Del Fiore P, Caminiti R, Rastrelli M, Mocellin S. PMID: 42511737 [PubMed - in process]
	Interleukin-1Î² Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy. Genes (Basel) Cauci S, Buligan C, Bazzichetto L, Petris G, Stinco G. PMID: 42510826 [PubMed - in process]
	Uveal melanoma as a stress-dependent malignancy governed by a reprogrammable stress-adaptation network. Transl Oncol Wang T, Chang A, Bai J, Liu Z, Wu Z. PMID: 42508144 [PubMed - as supplied by publisher]
	Clinical Robustness of FDG-PET/CT Quantitative Metrics Post-Harmonization in a Multicenter, Cross-Scanner Setting. Tomography Hino A, Ishiwata Y, Kakiuchi A, Numata T, Kamide H, Kurihara H, Sekikawa Z, Utsunomiya D. PMID: 42506869 [PubMed - indexed for MEDLINE]
	Oncological Care During a Crisis: A Systematic Review and Meta-Analysis of Non-Melanoma Skin Cancer of the Head and Neck Region in the COVID-19 Pandemic. Diseases Frosolini A, Benedetti S, Vaira LA, Gabriele G, Gennaro P. PMID: 42505582 [PubMed]
	A Weighted Neural Network Model Based on Laboratory Tests for Identifying Lymph Node Metastases in Esophageal Squamous Cell Carcinomas. Biosensors (Basel) Ouyang Q, Gao Z, Yang J, Wang S, Li Z, Zhang Y, Chen T, Xu X, Han R, Chen H. PMID: 42505453 [PubMed - indexed for MEDLINE]
	Interleukin-1Î² Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case-Control Study. Curr Oncol Cauci S, Buligan C, Nacci P, Petris G, Stinco G. PMID: 42505240 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 144065

Page 1 of 7204



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy